Moderna reports ‘robust’ Covid vaccine response in children aged 6-11

  WASHINGTON, United States (AFP) — US pharmaceutical giant Moderna on Monday reported a “robust neutralizing antibody response” to its Covid vaccine in children aged 6-11, and said that it will submit the trial data to global regulators soon. “We are encouraged by the immunogenicity and safety profile of mRNA-1273 in children aged 6 to under 12 years and are pleased that the study met its primary immunogenicity endpoints,” chief executive Stephane Bancel said in […]